Clinical Trial

Reducing Pain With Methadone and Ketamine in Liver Transplant

Study acronym: RELIEF-LT
Completed Phase 4
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn if using methadone and ketamine during an adult deceased donor liver transplant can help decrease pain after surgery. The main questions it aims to answer are: * What impact does using methadone and ketamine during a deceased donor liver transplant have on pain after surgery? * Does the use of methadone and ketamine also have an impact on mental confusion (delirium) after surgery? Researchers will compare the use of methadone and ketamine to standard of care to see if the two drugs work to decrease pain and impact delirium after liver transplant. Participants will: * Receive either methadone and ketamine or standard of care during their deceased donor liver transplant. * Allow researchers to follow medical care throughout inpatient stay.
Protocol Amendment History 3 changes
critical Trial completed 2026-08-12
notable Primary completion moved earlier: 2026-07-01 -> 2026-03-01 2026-08-12
minor Completion moved earlier: 2026-09-01 -> 2026-06-01 2026-08-12
Trial Details
NCT Number NCT06868589
Lead Sponsor Lahey Clinic
Conditions Liver Transplantation
Enrollment 50 participants
Start Date 2025-06-30
Primary Completion 2026-03-01 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-11